Early Career Shift Serendipitous for Kinaset CEO Robert Clarke, Asthma Patients

The problem Kinaset is trying to solve is that over time, patients receiving asthma therapies – typically inhaled corticosteroids plus bronchodilators – become steroid-refractory.

Related Keywords

United Kingdom ,Dublin ,Ireland ,Belgium ,Frazer Morgan ,Robert Clarke ,Roger Heerman ,Robert Connelly ,Johns Hopkins University ,Alkermes ,Harvard University ,Vectura Group ,Enbiotix Inc ,Courtesy Kinaset ,Johns Hopkins ,Resume ,Careers ,Arly Career Shift Serendipitous For Kinaset Ceo Robert Clarke ,Asthma Patients ,Iospace ,Advice ,